Post-hoc analysis of the Diabetes Prevention Trial-Type 1 (DPT-1), where at risk children were fed high doses of insulin, also indicated that it may be necessary to select individuals with high IAA levels for antigen-specific trials with insulin (129). This evidence concerns the gene INS and diabetes mellitus.